Management and prognosis of cancers in the accessory parotid gland

J Int Med Res. 2018 Dec;46(12):4930-4933. doi: 10.1177/0300060518767792. Epub 2018 Oct 5.

Abstract

Objective: This study was performed to analyze the clinical management of accessory parotid gland (APG) cancer and possible risk factors for disease-related death.

Methods: Patients diagnosed with primary APG cancers in the largest medical center in Northeast China were enrolled from January 1990 to December 2016.

Results: All 43 patients underwent resection of the tumors and superficial parotid gland by a standard Blair incision. Seven (16.3%) patients also required selective neck dissection. The most common lesion was mucoepidermoid carcinoma. Temporary facial paralysis occurred in 11 (25.6%) patients, and permanent facial paralysis occurred in 3 (7.0%) patients because of surgical resection of the facial nerve, which was involved with the tumor. The 5- and 10-year disease-specific survival rates were 86.0% and 66.0%, respectively. The tumor stage, neck status, neck dissection, and tumor grade were significantly associated with disease-related death, but only the tumor grade was an independent risk factor.

Conclusion: Superficial parotidectomy is a reliable surgical procedure associated with a high survival rate and low morbidity in treating APG cancers. The tumor grade is the key prognostic factor.

Keywords: Accessory parotid gland; parotid cancer; parotid gland; parotidectomy; prognostic analysis; tumor grade.

MeSH terms

  • Adult
  • Aged
  • Case-Control Studies
  • Disease Management
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Middle Aged
  • Parotid Gland / pathology*
  • Parotid Gland / surgery*
  • Parotid Neoplasms / pathology*
  • Parotid Neoplasms / surgery*
  • Postoperative Complications*
  • Prognosis
  • Survival Rate